Onychomycosis in Taiwan

International Journal of Clinical Practice

Volumn 59, Issue 8, 2005, Pages 906-911

  Wang, S H ^a   Chi, Ching Chi ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Onychomycosis; Pathogen; Taiwan

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANDIDA; CONTROLLED STUDY; DERMATOPHYTE; DRUG CHOICE; FEMALE; FINGERNAIL ONYCHOMYCOSIS; FUNGUS CULTURE; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOULD; NONHUMAN; ONYCHOMYCOSIS; OUTPATIENT DEPARTMENT; PARONYCHIA; PRIORITY JOURNAL; SEX RATIO; SOUTHERN EUROPE; TAIWAN; TOENAIL ONYCHOMYCOSIS; TROPICS; WESTERN HEMISPHERE; ARTHRODERMA; CLIMATE; DEUTEROMYCETES; HAND DISEASE; MICROBIOLOGY; MIDDLE AGED; MUCOCUTANEOUS CANDIDIASIS; NAIL; SKIN DISEASE;

ADULT; AGE DISTRIBUTION; ARTHRODERMATACEAE; CANDIDIASIS, CUTANEOUS; CLIMATE; FEMALE; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; MALE; MIDDLE AGED; MITOSPORIC FUNGI; NAILS; ONYCHOMYCOSIS; SEX DISTRIBUTION; TAIWAN;

EID: 33644659395     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2005.00497.x     Document Type: Article

References (40)

1. Scher RK. Onychomycosis: A significant medical disorder. J Am Acad Dermatol 1996; 35: S2-5.
2. Bending A. Fungal nail infections: Far more than an aesthetic problem. Br J Community Nurs 2002; 7: 254-9.
3. English MP. Nails and fungi. Br J Dermatol 1976; 94: 697-701.
4. Summerbell RC, Kane J, Krajden S. Onychomycosis, tinea pedis and tinea manuum caused by non-dermatophytic filamentous fungi. Mycoses 1989; 32: 609-19.
5. Elewski BE. Large-scale epidemiological study of the causal agents of onychomycosis: Mycological findings from the Multicenter Onychomycosis Study of Terbinafine. Arch Dermatol 1997; 133: 1317-8.
6. Gupta AK, Jain HC, Lynde CW et al. Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: A multicenter Canadian survey of 15,000 patients. J Am Acad Dermatol 2000; 43: 244-8.
7. Clayton YM. Clinical and mycological diagnostic aspects of onychomycoses and dermatomycoses. Clin Exp Dermatol 1992; 17 (Suppl.): 37-40.
8. Baran R, Hay RJ, Tosti A et al. A new classification of onychomycosis. Br J Dermatol 1998; 139: 567-71.
9. Pierard GE, Arrese JE, De Doncker P et al. Present and potential diagnostic techniques in onychomycosis. J Am Acad Dermatol 1996; 34: 273-7.
10. Weinberg JM, Koestenblatt EK, Tutrone WD et al. Comparison of diagnostic methods in the evaluation of onychomycosis. J Am Acad Dermatol 2003; 49: 193-7.
11. Reisberger EM, Abels C, Landthaler M et al. Histopathological diagnosis of onychomycosis by periodic acid-Schiff-stained nail clippings. Br J Dermatol 2003; 148: 749-54.
12. Baran R, Dawber RPR, de Berker DAR et al. Baran and Dawber's Diseases of the Nails and their Management, 3rd edn. London: Blackwell Science, 2001.
13. Zabawski EJ Jr, Styles AR, Cockerell CJ. Routine periodic acid-Schiff staining of nail plate fragments in fungal cultures for onychomycosis: A method to increase the sensitivity of diagnosis. Cutis 2000; 66: 456-8.
14. Suarez SM, Silvers DN, Scher RK et al. Histologic evaluation of nail clippings for diagnosing onychomycosis. Arch Dermatol 1991; 127: 1517-9.
15. Gianni C, Morelli V, Cerri A et al. Usefulness of histological examination for the diagnosis of onychomycosis. Dermatology 2001; 202: 283-8.
16. Darkes MJ, Scott LJ, Goa KL. Terbinafine: A review of its use in onychomycosis in adults. Am J Clin Dermatol 2003; 4: 39-65.
17. Brautigam M, Nolting S, Schopf RE et al. Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. BMJ 1995; 311: 919-22.
18. De Backer M, De Keyser P, De Vroey C et al. A 12-week treatment for dermatophyte toe onychomycosis: Terbinafine 250 mg/day vs. itraconazole 200 mg/day - a double-blind comparative trial. Br J Dermatol 1996; 134 (Suppl.): 16-17 (discussion 38).
19. Evans EG, Sigurgeirsson B. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. BMJ 1999; 318: 1031-5.
20. Sigurgeirsson B, Olafsson JH, Steinsson JB et al. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: A 5-year blinded prospective follow-up study. Arch Dermatol 2002; 138: 353-7.
21. Crawford F, Young P, Godfrey C et al. Oral treatments for toenail onychomycosis: A systematic review. Arch Dermatol 2002; 138: 811-6.
22. Segal R, Kritzman A, Cividalli L et al. Treatment of Candida nail infection with terbinafine. J Am Acad Dermatol 1996; 35: 958-61.
23. Gupta AK, Shear NH. A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis. Drug Saf 2000; 22: 33-52.
24. Nolting S, Brautigam M, Weidinger G. Terbinafine in onychomycosis with involvement by non-dermatophytic fungi. Br J Dermatol 1994; 130 (Suppl.): 16-21.
25. De Doncker PR, Scher RK, Baran RL et al. Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: A multicenter study with 36 patients. J Am Acad Dermatol 1997; 36: 173-7.
26. Haria M, Bryson HM, Goa KL. Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections. Drugs 1996; 51: 585-620.
27. Gupta AK, Einarson TR, Summerbell RC et al. An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Drugs 1998; 55: 645-74.
28. Ellabib MS, Agaj M, Khalifa Z et al. Yeasts of the genus Candida are the dominant cause of onychomycosis in Libyan women but not men: Results of a 2-year surveillance study. Br J Dermatol 2002; 146: 1038-41.
29. Roberts DT, Taylor WD, Boyle J. Guidelines for treatment of onychomycosis. Br J Dermatol 2003; 148: 402-10.
30. Rigopoulos D, Katsiboulas V, Koumantaki E et al. Epidemiology of onychomycosis in southern Greece. Int J Dermatol 1998; 37: 925-8.
31. Gianni C, Cerri A, Crosti C. Non-dermatophytic onychomycosis. An underestimated entity? A study of 51 cases. Mycoses 2000; 43: 29-33.
32. Khosravi AR, Mansouri P. Onychomycosis in Tehran, Iran: Prevailing fungi and treatment with itraconazole. Mycopathologia 2001; 150: 9-13.
33. Bokhari MA, Hussain I, Jahangir M et al. Onychomycosis in Lahore, Pakistan. Int J Dermatol 1999; 38: 591-5.
34. Ng KP, Saw TL, Madasamy M et al. Onychomycosis in Malaysia. Mycopathologia 1999; 147: 29-32.
35. Labor Market Statistics, October 2003. London: National Statistics, 2003.
36. Statistical Abstracts of the United States: 2002. Washington, DC: US Census Bureau, 2002.
37. 2001 Consensus. Ottawa: Statistics Canada, 2003.
38. Central Intelligence Agency. The World Fact Book Washington, DC: Central Intelligence Agency, 2003.
39. Council of Agriculture Executive Yuan. Agricultural Statistics Yearbook 2002 Taipei 2002.
40. Gianni C, Cerri A, Crosti C. Non-dermatophytic onychomycosis. An underestimated entity? A study of 51 cases. Mycoses 2000; 43: 29-33.